Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-009645

President and CEO acquired 226,173 shares (grant or award)

  • President and CEO acquired 26,867 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schultz Kare · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-09 Exercise or conversion : show line 1 in the form +26,867 509,661 D
2021-02-09 Grant or award : show line 2 in the form +226,173 735,834 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-09 Exercise or conversion : show line 3 in the form Restricted Share Units −26,867 26,867 D
Loading xslF345X03/doc4.xml…